Currently, ACR Image Metrix utilizes three global outposts, providing assistance to those overseas conducting a clinical study. From the birth of the company in 2007 to present, ACR Image Metrix has conducted over 34 trials in North America,more than 28 trials in Europe and over 14 trials in Asia.
The ACR Image Metrix team has worked to complete studies in over 30 countries around the world. ACR Image Metrix has performed site training, evaluation and qualification to multiple centers globally, including Western Europe, North America, South America, South Africa, Middle East (Israel, Saudi Arabia), Eastern Europe, Asia (South Korea, Singapore) and Australia.
ACR Image Metrix specializes in providing imaging CRO services to assist pharmaceutical, biotech and medical device companies.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Fast Tracks Johnson & Johnson’s Nipocalimab for Fetal Neonatal Alloimmune Thrombocytopenia
March 27th 2024Johnson & Johnson is moving forward with a pair of Phase III trials of nipocalimab to reduce the risk of fetal neonatal alloimmune thrombocytopenia in alloimmunized pregnant patients.